Peripheral haemodynamic effects of combined oestrogen-progestogen oral contraceptives.
D000293:Adolescent; D000328:Adult; D001783:Blood Flow Velocity; D001835:Body Weight; D003276:Contraceptives, Oral / Q000494:pharmacology*; D004338:Drug Combinations; D004967:Estrogens; D005260:Female; D005542:Forearm / Q000098:blood supply; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D006940:Hyperemia; D007511:Ischemia; D008234:Lynestrenol / Q000494:pharmacology*; D008656:Mestranol / Q000494:pharmacology*; D009132:Muscles / Q000098:blood supply; D010991:Plethysmography; D011868:Radioisotopes; D012039:Regional Blood Flow / Q000187:drug effects; D012867:Skin / Q000098:blood supply; D014655:Vascular Resistance / Q000187:drug effects; D014978:Xenon
D003276:Contraceptives, Oral; D004338:Drug Combinations; D004967:Estrogens; D006454:Hemoglobins; D011868:Radioisotopes; D014978:Xenon; D008656:Mestranol; D008234:Lynestrenol